In Vivo is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Calibra Medical (formerly Seattle Medical Technologies) brought in $35mm via its Series B financing led by first-time backer Canaan Partners. Other new investors Intersouth Partners and Skyline Ventures were joined by returning shareholders Frazier Healthcare Ventures and Three Arch Partners. The company will use the money for the anticipated 2009 launch of its easy-to-use insulin delivery device. Calibra has raised about $46mm since its formation in 2004. A member of Canaan and Skyline will join the board, with a representative from Skyline serving as a board observer.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?